Results 31 to 40 of about 24,572 (190)

Diabetic Pyomyositis: A Forgotten Entity?—A Case Report [PDF]

open access: yesBengal Physician Journal
Tropical pyomyositis is an infectious disease that primarily targets skeletal muscle, presenting either as a widespread inflammation or a rapidly progressing necrotic process.
Ankan Pathak   +6 more
doaj   +1 more source

Importance of Phenotyping Minor Blood Group Antigen in Renal Transplant Donors: A Retrospective Cohort Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2023
Introduction: Various studies have implicated minor antigens with increased graft rejection in the long term, especially in alloimmunised patients. Recipient’s antibody testing is done exhaustively during each case of rejection. However, without data
Sujata Mallick   +2 more
doaj   +1 more source

Knowledge, Attitudes, and Practices of Adverse Drug Reactions among a Spectrum of Health Workers: A Pharmacovigilance Study from a Teaching Hospital in Eastern India [PDF]

open access: yesBengal Physician Journal
Introduction: This research paper examines the knowledge, attitudes, and practices (KAP) of adverse drug reactions (ADRs) among healthcare professionals in a teaching hospital in eastern India.
Aditi Maitra   +3 more
doaj   +1 more source

Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2018
ABSTRACT The imipenem-relebactam combination is in development as a potential treatment regimen for infections caused by Enterobacteriaceae possessing complex β-lactamase backgrounds. Relebactam is a β-lactamase inhibitor that possesses the diazabicyclooctane core, as in avibactam; however, the R1 side ...
Krisztina M, Papp-Wallace   +9 more
openaire   +2 more sources

Guillain–Barré Syndrome developing in a Patient with Graves’ Disease

open access: yesJournal of the ASEAN Federation of Endocrine Societies, 2019
Graves' disease (GD) and Guillain-Barre syndrome (GBS) are both autoimmune disorders and are triggered by interactions between genetic and environmental factors.
Anirban Majumder, Sagar Basu
doaj   +1 more source

Active surveillance for KPC-experiencereport [PDF]

open access: yesBMC Proceedings, 2011
Bacterial resistance to antimicrobials has increased over the years, but the importance of empirical investigation of these bacteria contributes to the prevention of spread within the institution. The Infection Control Comission Protocol has as surveillance for resistant organisms since 1996.In Brazil, Klebsiela pneumoniae carbapenemase enzyme (KPC ...
Zogheib CT   +3 more
openaire   +2 more sources

Emergence of KPC-producing Klebsiella pneumoniae in Italy [PDF]

open access: yesBMC Research Notes, 2010
The emergence of KPC-producing K. pneumoniae has now become a global concern. KPC beta-lactamases are plasmid-borne and, like extended spectrum beta lactamases (ESBLs), can accumulate and transfer resistance determinants to other classes of antibiotics.
FONTANA, CARLA   +8 more
openaire   +5 more sources

Concomitant carriage of KPC-producing and non-KPC-producing Klebsiella pneumoniae ST512 within a single patient [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 2020
Abstract Background KPC-producing Klebsiella pneumoniae of clonal group 258 are prominent in healthcare settings in many regions of the world. The blaKPC gene is mostly carried by a multireplicon IncFIIk-IncFI plasmid suspected to be highly compatible and stable in this genetic background.
Jousset, Agnès   +8 more
openaire   +3 more sources

KPC-producing Enterobacter aerogenes infection

open access: yesThe Brazilian Journal of Infectious Diseases, 2015
Enterobacter is a common nosocomial microorganism and its carbapenem's resistance has increased. The management of these cases is unclear.We evaluated 16 patients with KPC-producing Enterobacter aerogenes infections, detailing the site of infection, therapy, clinical and epidemiological data.A retrospective and descriptive study.
Tuon F. F.   +5 more
openaire   +4 more sources

Characterization of Corosolic Acid as a KPC-2 Inhibitor That Increases the Susceptibility of KPC-2-Positive Bacteria to Carbapenems [PDF]

open access: yesFrontiers in Pharmacology, 2020
The emergence of KPC-producing Gram-negative bacteria in clinical practice highlights the need to search for novel antimicrobials and new anti-infection strategies. In this study, we constructed a laboratory KPC-2-positive strain, E. coli BL21(DE3) (pET28a-KPC-2) and identified the activity of KPC-2 in this strain.
Yonglin Zhou   +10 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy